PPLPHARMA Piramal Pharma Ltd Expansion Plans Announcement 2024 - Financial Results Update Piramal Pharma Ltd reported strong financial results for Q2 and H1 FY25, with a 17% YoY growth in revenue and a 28% increase in EBITDA; they also announced an $80 million expansion plan at their Lexington facility expected to complete by FY27..Find Corporate Announcements for Press Releases, AGM, Insider Trading & SAST, Results and Corporate Action for Piramal Pharma Ltd